z-logo
Premium
Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir
Author(s) -
Koonsaeng Suphannee,
Verschraegen Claire,
Freedman Ralph,
Bossens Michel,
Kudelka Andrzej,
Kavanagh John,
Sittisomwong Tul,
DeClercq Erik,
Snoeck Robert
Publication year - 2001
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.1036
Subject(s) - cidofovir , isotretinoin , virology , medicine , human papillomavirus , interferon , vulvar intraepithelial neoplasia , dermatology , intraepithelial neoplasia , virus , vulva , acne , cancer , prostate
Vulvar intraepithelial neoplasias are difficult to eradicate completely without extensive surgical intervention. Cidofovir, a deoxycytidine monophosphate analog, may have a therapeutic role in this disease. A 43‐year‐old woman with a 20‐year history of genital warts presented with extensive vulvar intraepithelial neoplasia III, and refused surgical resection. Topical cidofovir 1% in Beeler base completely eradicated the lesion. Successive treatment applications, however, were necessary. Cidofovir is a promising topical antiviral compound for HPV induced vulvar intraepithelial neoplasia. J. Med. Virol. 64:195–198, 2001. © 2001 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom